Myeloid Cell Contribution to Tumor Lesion Composition and Outcome iconMyeloid Cell Contribution to Tumor Lesion Composition and Outcome

Myeloid Cell Contribution to Tumor Lesion Composition and Outcome

Jan 27, 2021 5:00pm ‐ Jan 27, 2021 5:25pm
Immune Cell Biology: Implications for Cellular Immunotherapy iconImmune Cell Biology: Implications for Cellular Immunotherapy

Immune Cell Biology: Implications for Cellular Immunotherapy

Jan 27, 2021 5:00pm ‐ Jan 27, 2021 8:00pm
Regulation of T Cell Function in Tumors iconRegulation of T Cell Function in Tumors

Regulation of T Cell Function in Tumors

Jan 27, 2021 5:25pm ‐ Jan 27, 2021 5:50pm
NK Cells in Health and Disease iconNK Cells in Health and Disease

NK Cells in Health and Disease

Jan 27, 2021 5:50pm ‐ Jan 27, 2021 6:15pm
Coffee Break iconCoffee Break

Coffee Break

Jan 27, 2021 6:15pm ‐ Jan 27, 2021 6:45pm
Short Talk: Disrupting Enhancers within the Core Epigenetic Program of Exhaustion Improves CD8+ T Cell Responses and Enhances Tumor Control iconShort Talk: Disrupting Enhancers within the Core Epigenetic Program of Exhaustion Improves CD8+ T Cell Responses and Enhances Tumor Control

Short Talk: Disrupting Enhancers within the Core Epigenetic Program of Exhaustion Improves CD8+ T Cell Responses and Enhances Tumor Control

Jan 27, 2021 6:45pm ‐ Jan 27, 2021 7:00pm
Short Talk: Mapping Cellular Interactions between Cancer and Normal Cells via Synthetic Notch Ligand/Receptor Pairs iconShort Talk: Mapping Cellular Interactions between Cancer and Normal Cells via Synthetic Notch Ligand/Receptor Pairs

Short Talk: Mapping Cellular Interactions between Cancer and Normal Cells via Synthetic Notch Ligand/Receptor Pairs

Jan 27, 2021 7:00pm ‐ Jan 27, 2021 7:15pm
Short Talk: Unbiased Design of Engineered T Cell Therapies Using Functional CRISPR/Cas9 Screens iconShort Talk: Unbiased Design of Engineered T Cell Therapies Using Functional CRISPR/Cas9 Screens

Short Talk: Unbiased Design of Engineered T Cell Therapies Using Functional CRISPR/Cas9 Screens

Jan 27, 2021 7:15pm ‐ Jan 27, 2021 7:30pm
Short Talk: Uncovering the Cell-Type Specificity in Human T1D Immune Activation Using iPSC-beta Cells iconShort Talk: Uncovering the Cell-Type Specificity in Human T1D Immune Activation Using iPSC-beta Cells

Short Talk: Uncovering the Cell-Type Specificity in Human T1D Immune Activation Using iPSC-beta Cells

Jan 27, 2021 7:30pm ‐ Jan 27, 2021 7:45pm
Closing Remarks iconClosing Remarks

Closing Remarks

Jan 27, 2021 7:45pm ‐ Jan 27, 2021 8:00pm